Epilepsy Research and Treatment / 2013 / Article / Tab 1

Review Article

Temporal Lobe Resective Surgery for Medically Intractable Epilepsy: A Review of Complications and Side Effects

Table 1

Synopsis of data of pediatric temporal lobe epilepsy surgical series and their reported complications.

Series/year of publicationStudy characteristicsNumber of ptsSurgical procedureMortalityMean
followup
Seizure-free
outcome
ComplicationsCumulative complication rate*Behavioral/cognitive/psychiatric
complications

Erba et al.,
1992 [18]
Prospective, pediatric & adolescent46Standard ATL + AH0%5 years85%Infection: 2.1%
Hemiparesis/hemianopsia: 4.3%
C.N. Palsy: 2.1%
17.1%Depression: 4.3%
Behavioral syndrome: 4.3%

Sinclair et al.,
2003 [19]
Retrospective, pediatric32Standard ATL0%6.9 years76%Infection: 3.1%
Hydrocephalus: 3.1%
Stroke: 3.1%
9.3%N/A

Terra-Bustamante et al.,
2005 [20]
Prospective, pediatric & adolescent35Standard ATL + AH 0%3.5 years77.1%Hemianopsia: 2.9%2.9%N/A

Kim et al.,
2008 [9]
Prospective, pediatric59Standard ATL + AH0%62.3 months69%VFDs: 22.0%
Hemiparesis: 8.5%
Wound infection: 8.5%
Meningitis: 3.4%
47.5%Psychosis: 5.1%

Lopez-Gonzalez et al.,
2012 [6]
Retrospective, pediatric130Cortico-amygdalo-hippocampectomy (CAH),
Lesionectomy + CAH,
Lesionectomy,
neocortical resection,
tailored ATL + AH,
selective AH
0%2 years72%VFDs: 1.5%
Transient speech Difficulties: 0.7%
Infection: 1.5%
17%Depression: 10%

Vadera et al.,
2012 [13]
Retrospective, pediatric45Standard ATL + AH0%60.2 months69%None0%N/A

This rate includes the behavioral/cognitive/psychiatric complications. ATL: anterior temporal lobectomy; AH: amygdalohippocampectomy; VFDs: visual field deficits; C.N.: cranial nerve.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.